InMed Pharmaceuticals (INM) Net Shares Issued and Repurchased (2023 - 2025)

InMed Pharmaceuticals has reported Net Shares Issued and Repurchased for 3 years, with the latest figure at $1054.0 in Q3 2025.

• On a quarterly basis, Net Shares Issued and Repurchased changed N/A year-over-year to $1054.0 in Q3 2025; TTM through Sep 2025 was $1054.0, a N/A change from a year earlier, with the FY2025 full-year figure at $28700.0, down 1.1% from the prior year.
• Net Shares Issued and Repurchased was $1054.0 for Q3 2025 at InMed Pharmaceuticals, down from $28700.0 in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $61720.0 in Q2 2023, with the low at $509.0 in Q3 2023.
• Average Net Shares Issued and Repurchased over 3 years is $24200.6, with a median of $28700.0 recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: Net Shares Issued and Repurchased plunged 52.98% in 2024, then declined 1.1% in 2025.
• Over 3 years, Net Shares Issued and Repurchased stood at $509.0 in 2023, then jumped by 5601.38% to $29020.0 in 2024, then slumped by 96.37% to $1054.0 in 2025.
• The last three Net Shares Issued and Repurchased figures came in at $1054.0 (Q3 2025), $28700.0 (Q2 2025), and $29020.0 (Q2 2024), per Business Quant data.